| International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors BB Fredholm, AP IJzerman, KA Jacobson, KN Klotz, J Linden Pharmacological reviews 53 (4), 527-552, 2001 | 3299 | 2001 |
| VI. Nomenclature and classification of purinoceptors B Fredholm, M Abbracchio, G Burnstock, J Daly, K Harden, K Jacobson, ... The Journal of Pharmacology and Experimental Therapeutics 46 (2), 143, 1994 | 2040 | 1994 |
| Adenosine receptors as therapeutic targets KA Jacobson, ZG Gao Nature reviews Drug discovery 5 (3), 247-264, 2006 | 1625 | 2006 |
| International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy MP Abbracchio, G Burnstock, JM Boeynaems, EA Barnard, JL Boyer, ... Pharmacological reviews 58 (3), 281-341, 2006 | 1496 | 2006 |
| International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors—an update BB Fredholm, AP IJzerman, KA Jacobson, J Linden, CE Müller Pharmacological reviews 63 (1), 1-34, 2011 | 1429 | 2011 |
| Structure of an agonist-bound human A2A adenosine receptor F Xu, H Wu, V Katritch, GW Han, KA Jacobson, ZG Gao, V Cherezov, ... Science 332 (6027), 322-327, 2011 | 906 | 2011 |
| UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis S Koizumi, Y Shigemoto-Mogami, K Nasu-Tada, Y Shinozaki, K Ohsawa, ... Nature 446 (7139), 1091-1095, 2007 | 821 | 2007 |
| The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 176, S21-S141, 2019 | 659 | 2019 |
| Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential KA Jacobson, PJM Van Galen, M Williams Journal of medicinal chemistry 35 (3), 407-422, 1992 | 657 | 1992 |
| Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors HK Eltzschig, JC Ibla, GT Furuta, MO Leonard, KA Jacobson, K Enjyoji, ... The Journal of experimental medicine 198 (5), 783-796, 2003 | 558 | 2003 |
| Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family MP Abbracchio, JM Boeynaems, EA Barnard, JL Boyer, C Kennedy, ... Trends in pharmacological sciences 24 (2), 52-55, 2003 | 551 | 2003 |
| Recent developments in adenosine receptor ligands and their potential as novel drugs CE Müller, KA Jacobson Biochimica et Biophysica Acta (BBA)-Biomembranes 1808 (5), 1290-1308, 2011 | 463 | 2011 |
| Towards a revised nomenclature for P1 and P2 receptors BB Fredholm, MP Abbracchio, G Burnstock, GR Dubyak, TK Harden, ... Trends in pharmacological sciences 18 (3), 79, 1997 | 451 | 1997 |
| Structure of the human P2Y12 receptor in complex with an antithrombotic drug K Zhang, J Zhang, ZG Gao, D Zhang, L Zhu, GW Han, SM Moss, ... Nature 509 (7498), 115-118, 2014 | 397 | 2014 |
| Purine and pyrimidine (P2) receptors as drug targets KA Jacobson, MF Jarvis, M Williams Journal of medicinal chemistry 45 (19), 4057-4093, 2002 | 395 | 2002 |
| Adenosine A3 receptors: novel ligands and paradoxical effects KA Jacobson Trends in pharmacological sciences 19 (5), 184-191, 1998 | 369 | 1998 |
| Adenosine A3 receptor stimulation and cerebral ischemia DKJE Von Lubitz, RCS Lin, P Popik, MF Carter, KA Jacobson European journal of pharmacology 263 (1-2), 59-67, 1994 | 332 | 1994 |
| Adenosine receptor ligands: differences with acute versus chronic treatment KA Jacobson, DKJE von Lubitz, JW Daly, BB Fredholm Trends in pharmacological sciences 17 (3), 108-113, 1996 | 328 | 1996 |
| Two disparate ligand-binding sites in the human P2Y1 receptor D Zhang, ZG Gao, K Zhang, E Kiselev, S Crane, J Wang, S Paoletta, C Yi, ... Nature 520 (7547), 317-321, 2015 | 323 | 2015 |
| Agonist-bound structure of the human P2Y12 receptor J Zhang, K Zhang, ZG Gao, S Paoletta, D Zhang, GW Han, T Li, L Ma, ... Nature 509 (7498), 119-122, 2014 | 319 | 2014 |
Geoffrey BurnstockUniversity College Medical School, University College LondonVerified email at ucl.ac.uk
